AVIRAGEN THERAPEUTICS INC's ticker is AVIR and the CUSIP is 053761102. A total of 32 filers reported holding AVIRAGEN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $0 | -100.0% | 22 | -100.0% | 0.00% | – |
| Q3 2017 | $100,000 | +7.5% | 146,292 | +4.4% | 0.00% | – |
| Q2 2017 | $93,000 | – | 140,170 | +637036.4% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 22 | -100.0% | 0.00% | – |
| Q4 2016 | $408,000 | -21.2% | 332,904 | +23.2% | 0.00% | – |
| Q3 2016 | $518,000 | +67.1% | 270,224 | +21.9% | 0.00% | – |
| Q2 2016 | $310,000 | – | 221,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 2,836,326 | $1,848,000 | 0.60% |
| SENZAR ASSET MANAGEMENT, LLC | 1,725,176 | $1,125,000 | 0.28% |
| Broadfin Capital, LLC | 3,179,226 | $2,072,000 | 0.25% |
| Stonepine Capital Management, LLC | 314,421 | $205,000 | 0.12% |
| TOWERVIEW LLC | 180,000 | $117,000 | 0.06% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 224,477 | $146,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 204,470 | $133,000 | 0.00% |
| Renaissance Technologies | 713,005 | $465,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 79,796 | $52,000 | 0.00% |
| WEDBUSH SECURITIES INC | 10,500 | $7,000 | 0.00% |